Barclays PLC Purchases 3,118 Shares of Utah Medical Products, Inc. (NASDAQ:UTMD)

Barclays PLC raised its holdings in shares of Utah Medical Products, Inc. (NASDAQ:UTMD) by 214.1% during the third quarter, HoldingsChannel.com reports. The firm owned 4,574 shares of the medical instruments supplier’s stock after acquiring an additional 3,118 shares during the quarter. Barclays PLC’s holdings in Utah Medical Products were worth $306,000 at the end of the most recent quarter.

Other hedge funds also recently modified their holdings of the company. Copeland Capital Management LLC acquired a new position in Utah Medical Products in the third quarter valued at approximately $53,000. BNP Paribas Financial Markets raised its position in shares of Utah Medical Products by 102.7% during the 3rd quarter. BNP Paribas Financial Markets now owns 1,117 shares of the medical instruments supplier’s stock valued at $75,000 after acquiring an additional 566 shares during the last quarter. Allspring Global Investments Holdings LLC acquired a new position in shares of Utah Medical Products in the 2nd quarter valued at $83,000. Victory Capital Management Inc. boosted its position in shares of Utah Medical Products by 124.4% in the 2nd quarter. Victory Capital Management Inc. now owns 2,673 shares of the medical instruments supplier’s stock worth $179,000 after purchasing an additional 1,482 shares during the last quarter. Finally, GSA Capital Partners LLP acquired a new stake in shares of Utah Medical Products during the third quarter worth $231,000. Institutional investors own 69.60% of the company’s stock.

Utah Medical Products Stock Performance

Shares of NASDAQ:UTMD opened at $61.35 on Friday. The company has a 50 day moving average price of $64.06 and a two-hundred day moving average price of $66.17. The company has a market capitalization of $208.10 million, a PE ratio of 14.37 and a beta of 0.08. Utah Medical Products, Inc. has a 52 week low of $60.39 and a 52 week high of $85.76.

Utah Medical Products Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, January 3rd. Investors of record on Monday, December 16th were paid a dividend of $0.305 per share. This represents a $1.22 annualized dividend and a yield of 1.99%. The ex-dividend date of this dividend was Monday, December 16th. This is an increase from Utah Medical Products’s previous quarterly dividend of $0.30. Utah Medical Products’s dividend payout ratio (DPR) is presently 28.57%.

Analyst Upgrades and Downgrades

Separately, StockNews.com lowered Utah Medical Products from a “strong-buy” rating to a “buy” rating in a research note on Thursday, November 7th.

Utah Medical Products Profile

Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.